Stock AKRO AKERO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akero Therapeutics, Inc.

Equities

AKRO

US00973Y1082

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-10 EDT 		5-day change 1st Jan Change
19.65 USD -5.53% Intraday chart for Akero Therapeutics, Inc. -0.05% -15.85%
05-10 Akero Therapeutics' Q1 Net Loss Widens; Cash Expected to Fund Operations Into H2 2027 MT
04-30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKERO THERAPEUTICS, INC. Stock Akero Therapeutics, Inc.
 1.36B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. AKRO Stock
  4. Charts Akero Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW